PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma

Ghassan K. Abou-Alfa*, Stephan L. Chan, Chia Chi Lin, E. Gabriela Chiorean, Randall F. Holcombe, Mary F. Mulcahy, William D. Carter, Kashyap Patel, William R. Wilson, Teresa J. Melink, John C. Gutheil, Chao Jung Tsao

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds